body aches after glp 1 GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment GLP-1 Intolerance and Endoscopic Sleeve

Typically, Semaglutide GLP-1 injections are recommended for individuals with a BMI of 30 or higher, or 27 or higher with weight-related health conditions

For dual agonists: because they are stronger, the sideeffect profile may be similar or somewhat amplified

So far, studies on these new, multi-agonist drugs suggest that activating multiple receptors may lead to greater weight loss than GLP-1 alone

Mechanism: Same GLP-1 agonist as Ozempic/Wegovy, but in pill form (vs

Patients who were prescribed GLP-1s by providers with expertise in weight management and obesity such as endocrinologists and obesity specialists were more likely to complete at least12 weeks of treatment

Furthermore, alongside the increasing prevalence of related cardiometabolic diseases such as diabetes, obesity and chronic kidney disease (CKD), the number of people with HF has increased to around 64 million globally, amongst whom most are also living with type 2 diabetes or obesity (Groenewegen et al., 2020)